A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia

BACKGROUND: Bitopertin, a glycine reuptake inhibitor, was investigated as a novel treatment for schizophrenia. We report all the results of a double-blind randomized study assessing safety and efficacy following 52-week adjunctive treatment with bitopertin in Japanese patients with schizophrenia. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirayasu, Yoshio, Sato, Shin-Ichi, Takahashi, Hideaki, Iida, Sayaka, Shuto, Norifumi, Yoshida, Seitaro, Funatogawa, Takashi, Yamada, Takahito, Higuchi, Teruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791769/
https://www.ncbi.nlm.nih.gov/pubmed/26980460
http://dx.doi.org/10.1186/s12888-016-0778-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791769/
https://www.ncbi.nlm.nih.gov/pubmed/26980460
http://dx.doi.org/10.1186/s12888-016-0778-9

Ejemplares similares